References
- Stamler J. Circulation 1979; 60: 1575–1587
- Connor W. E., Connor S. J. Hyperlipidemia, Diagnosis and Therapy, B. M. Rifkind, R. I. Levy. Grune and Stratton, New York 1977; 281–326
- Nestel P. J., Ardlie N., Barter P., Blacket R. B., Quinlivan N., Reader S. R., Simons L. Med. J. Aust 1979; 2: 294–307
- Levy R. I., Morganroth J., Rifkind B. M. New Engl. J. Med. 1974; 290: 1295–1301
- Hunninghake D. B., Probstfield J. L. Hyperlipidemia, Diagnosis and Therapy, B. M. Rifkind, R. I. Levy. Grune and Stratton, New York 1977; 327–362
- Cayen M. N. Ann. Rep. Med. Chem 1979; 14: 198–208
- Carlson L. A., Olsson A. G. Prog. Biochem. Pharmacol 1979; 15: 238–257
- Schwandt P. Int. J. Clin. Pharmacol. Biopharm 1979; 17: 351–356
- Gugler R. Clin. Pharmacokinet 1978; 3: 425–439
- Kraml M., Robinson W. T. GLC and HPLC Determination of Therapeutic Agents, Part 3, K. Tsuji. Dekker, New York 1979; 1099–1128
- Thorp J. M. Lancet 1962; 1: 1323–1326
- Houin G., Thebault J. J., d'Athis P.-J., Tillement P., Beaumont J.-L. Eur. J. Clin. Pharmacol 1975; 8: 433–437
- Chasseaud L. F., Cooper A. J., Saggers V. H. J. Clin. Pharmacol 1974; 14: 382–386
- Piehardo R., Boulet L., Davignon J. Atherosclerosis 1977; 26: 573–582
- Sedaghat A., Ahrens E. H., Jr. Eur. J. Clin. Invest 1975; 5: 177–185
- Cayen M. N., Ferdinandi E. S., Greselin E., Robinson W. T., Dvornik D. J. Pharmacol. Exp. Ther 1977; 200: 33–43
- Mannisto P. T., Tuomisto J., Jounela A., Penttila O. Acta Pharmacol. Toxicol 1975; 36: 353–365
- Cailleux A., Allain P., Tadei A. Therapie 1976; 31: 637–645
- Taylor T., Chasseaud L. F. J. Pharm. Sci. 1977; 66: 1638–1639
- Harvengt C., Desager J. P. Int. J. Clin. Pharmacol 1976; 14: 113–118
- Gugler R., Kurten J. W., Jensen C. J., Klehr U., Hartlapp J. Eur. J. Clin. Pharmacol 1979; 15: 341–347
- De Sante K. A., Di Santo A. R., Albert K. S., Weber D. J., Welch R. D., Vecchio T. J. J. Clin. Pharmacol 1979; 19: 721–725
- Gugler R., Hartlapp J. Clin. Pharmacol. Ther 1978; 24: 432–438
- Thorp J. M. Proc. Eur. Soc. Study Drug Toxic 1972; 13: 98–109
- Baldwin J. R., Witiak D. T., Feller D. R. Fed. Proc 1977; 36: 962
- Loiseau G., Millischer R. J., Lohier P. Y., Mardiguian J. S., Pieux-Gilede A. M., Ginocchio A. V. J. Pharmacol. (Paris) 1978; 9: 166
- D'Costa M. A., Smigura F. C., Kulhay K., Angel A. J. Lab. Clin. Med. 1977; 90: 823–836
- Mackerer C. R., Haettinger J. R. J. Pharmacol. Exp. Ther 1978; 204: 683–689
- Crouthamel W. G., Cenedella R. J. Pharmacology 1975; 13: 465–473
- Wagner J. G., Northam D. I., Alway C. D., Carpenter O. S. Nature (London) 1965; 207: 1301–1302
- Faed E. M., McQueen E. G. Pharmacology 1974; 12: 144–151
- Harvengt C., Desager J. P. Curr. Ther. Res. 1976; 19: 145–151
- Taylor T., Chasseaud L. F., Darragh A., O'Kelly D. A. Eur. J. Clin. Pharmacol 1978; 13: 49–53
- Gugler R., Shoeman D. W., Huffman D. H., Cohlmia J. B., Azarnoff D. L. J. Clin. Invest 1975; J55: 1182–1189
- Dujovne C. A., Azarnoff D. L., Pentikainen P., Manion C., Hurwitz A., Hassanein K. Am. J. Med. Sci. 1976; 272: 277–284
- Harvengt C., Desager J. P. Int. J. Clin. Pharmacol 1977; 15: 1–4
- Paltauf F., Pristautz H., El Eisch I. A. Acta Med. Aust 1977; 4: 120–124
- Daae L. N. W., Aas M. Atherosclerosis 1973; 17: 389–400
- Kurup C. K. R., Chhabra S. Ind. J. Biochem. Biophys 1977; 14: 267–271
- Laker M. E., Mayes P. A. Biomedicine 1978; 29: 88–90
- Bridgman J. F., Rosen S. M., Thorp J. M. Lancet 1972; 2: 506–509
- Connor J. N., Johnson G. F., Solomon H. M. Clin. Chem 1976; 22: 884–888
- Bjornsson T. D., Blaschke T. F., Meffin P. J. J. Chromatogr 1977; 137: 145–152
- Mucklow J. C., Bending M. R., Kahn G. C., Do Uery C. T. Clin. Pharmacol. Ther 1978; 24: 563–570
- Pierides A. M., Alvarez-Ude F., Skillen A. W. Lancet 1975; 2: 1279–1281
- Reidenberg M. M. Am. J. Med. 1977; 62: 466–470
- Goldberg A. P., Sherrard D. J., Haas L. B., Brunzell J. D. Clin. Pharmacol. Ther 1977; 21: 317–325
- Di Giulio S., Boulu R., Drueke T., Nicolai A., Zingraff J., Crosnier J. Clin. Nephrol 1977; 8: 504–509
- Faed E. M., McQueen E. G. Br. J. Clin. Pharmacol 1979; 7: 407–410
- Barrett A. M. Int. J. Clin. Pharmacol 1969; 1: 29–32
- Meisner H. Mol. Pharmacol 1977; 13: 224–231
- Meisner H., Neet K. Mol. Pharmacol 1969; 14: 337–346
- Mason R. W. Pharmacology 1975; 13: 177–186
- Nazaretn R. I., Sokoloski T. D., Witiak D. T., Hopper A. T. J. Pharm. Sci. 1974; 63: 203–210
- Oliver M. F., Roberts S. D., Hayes D., Pantridge J. F., Suzman M. M., Bersohn I. Lancet 1963; 1: 143–144
- Rogen A. S., Ferguson J. C. J. Atheroscler. Res. 1963; 3: 671–676
- Solomon R. B., Rosner F. N. Y. State J. Med. 1973; 73: 2002–2003
- Bjornsson T. D., Meffin P. J., Swezey S., Blaschke T. F. J. Pharmacol. Exp. Ther 1979; 210: 316–321
- Solomon H. M., Schrogie J. J. Biochem. Pharmacol 1967; 16: 1219–1226
- Solomon H. M., Schrogie J. J., Williams D. Biochem. Pharmacol 1968; 17: 143–151
- Tillement J. P., Mattei C., Zini R. Experientia 1974; 30: 460–461
- Pond S. M., Graham G. G., Wade D. N., Sudlow G. Aust. N. Z. J. Med. 1975; 5: 324–328
- Sudlow G., Birkett D. J., Wade D. N. Clin. Exp. Pharmacol. Physiol 1975; 2: 129–140
- Veronich K., White G., Kapoor A. J. Pharm. Sci. 1979; 68: 1515–1518
- O'Reilly R. A., Sahud M. A., Robinson A. J. Thromb. Diath. Haemorrh 1972; 27: 309–318
- Bjornsson T. D., Meffin P. J., Blaschke T. F. J. Phar-macokinet. Biopharm 1977; 5: 495–505
- Yacobi A., Udall J. A., Levy G. Clin. Pharmacol. Ther 1976; 19: 552–558
- Solomon H. M., Reich S., Spirt N., Abrams W. B. Ann. N. Y. Acad. Sci. 1971; 179: 362–369
- Gold J. Proc. Am. Assoc. Cancer Res. 1976; 17: 67, Meet. 6
- Schiffman F. J., Fisher J. M., Rabinovitz M. Cancer Treat. Rep. 1977; 61: 1407–1410
- Sellers E. M. Pharmacology 1979; 18: 225–227
- Caldwell J., Emudianughe T. S., Smith R. L. Br. J. Pharmacol 1979; 66: 421P–422P
- Horning M. G., Hebert R. M., Roth R. J., Davis D. L., Horning E. C., Fischer E. P., Jordan G. L., Jr. Lipids 1972; 7: 114–120
- Faed E. M., McQueen E. G. Clin. Exp. Pharmacol. Physiol 1978; 5: 195–198
- Tschanz C., Hignite C. E., Lemons S., Huffman D. H., Azarnoff D. L. Clin. Res. 1978; 26: 655A
- Caldwell J., Emudianughe T. S. Biochem. Soc. Trans 1979; 7: 521–522
- Faedand E. M., McQueen E. G. Clin. Exp. Pharmacol. Physiol 1979; 6: 267–273
- Kutz K., Schulte A., Jensen C., Gugler R. Gastroenterology 1977; 13: 1229
- Weiner M. Drug. Metab. Rev. 1979; 9: 99–106
- Miller O. N., Hamilton J. G., Goldsmith G. A. Am. J. Clin. Nutr 1960; 8: 480–490
- Carlson L. A., Oro L., Ostman J. Acta Med. Scand 1965; 183: 457–465
- Lesne M., Sturbois X., Mercier M. Pharm. Acta Helv 1976; 51: 367–370
- Subissi A., Murmann W. Arzneim. -Forsch 1978; 28: 1143–1145
- Testa R., Gambini M., Canestrini C. Farmaco 1978; 33: 463–471
- Cayen M. N., Robinson W. T., Dubuc J., Dvornik D. Biochem. Pharmacol 1979; 28: 1163–1167
- Bechgaard H., Jesperson S. J. Pharm. Sci. 1977; 66: 871–872
- Frank O., Baker H., Sobotka H. Nature (London) 1963; 197: 490–491
- Svedmyr N., Harthon L., Lundholm L. Clin. Pharmacol. Ther 1969; 10: 559–570
- Carlson L. A. Metabolic Effects of Nicotinic Acid and Its Derivatives, K. F. Gey, L. A. Carlson. Huber, Bern 1971; 157–165
- Corr P. B., May D. G. J. Pharmacol. Exp. Ther 1975; 192: 195–200
- Pereira J. N. J. Lipid Res. 1967; 8: 239–244
- Carlson L. A., Oro L. Acta Med. Scand 1969; 186: 337–347
- Oliver M. F., Rowe M. J., Luxton M. R., Miller N. E., Neilson J. M. Circulation 1976; 53: 210, (Suppl. I)
- Fumagalli R. Metabolic Effects of Nicotinic Acid and Its Derivatives, K. F. Gey, L. A. Carlson. Huber, Bern 1971; 33–49
- Harthon J. G. L., Lindqvist J. T. Arzneim. -Forsch 1964; 14: 1170–1171
- Hertle H., Kiese M., Renner G. Arzneim. -Forsch 1979; 29: 114–116
- Svedmyr N., Harthon L. Acta Pharmacol. Toxicol 1970; 28: 66–74
- Sharma P. L., Garg S. K., Sikka S. C. Int. J. Clin. Pharmacol 1973; 7: 299–302
- Parwaresch M. R., Haacke H., Mader C. Atherosclerosis 1978; 31: 395–401
- Avogaro P., Bittolo-Bon G., Cazzolato G. Pharmacol. Res. Commun 1978; 10: 127–131
- Salmi H. A., Frey H. Curr. Ther. Res. 1974; 16: 669–674
- Puglisi L., Caruso V., Paoletti R. Pharmacol. Res. Commun 1976; 8: 379–386
- Gey K. F., Lengsfeld H., Raaflaub J. Metabolic Effects of Nicotinic Acid and Its Derivatives, K. F. Gey, L. A. Carlson. Huber, Bern 1971; 77–83
- Raaflaub J. Experientia 1966; 22: 258–259
- Schraepler P., Schultz E., Scholer A. Med. Welt 1977; 28: 1900–1903
- Lee K. W., Abelson D. M., Kwon Y. O. Am. J. Clin. Nutr 1968; 21: 223–225
- Beaumont J.-L., Dachet C. Atherosclerosis 1976; 25: 255–266
- Carlson L. A., Hanngren A. Life Sci 1964; 3: 867–871
- Carlson L. A., Nye E. R. Acta Med. Scand 1966; 179: 453–461
- Modestov V. K., Sokolov A. B. Tr. Tsentr. Inst. Usoversh. Vrachei 1964; 71: 194, cited in Ref. 94
- Smith R. L. Lipid Pharmacology, R. Paoletti. Academic, New York 1964; 461–488, and references cited
- Mrochek J. E., Jolley R. L., Young D. S., Turner W. J. Clin. Chem 1976; 22: 1821–1827
- Chang W. M. L., Johnson B. C. J. Nutr 1962; 76: 512–514
- van Eys J., Touster O., Darby W. J. J. Biol. Chem 1955; 217: 287–305
- Chang W. M. L., Johnson B. C. J. Biol. Chem 1959; 234: 1817–1821
- Chang W. M. L., Johnson B. C. J. Biol. Chem 1961; 236: 2096–2098
- Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Drugs 1978; 15: 409–428
- Arnold J. A., Martin D., Taylor H. L., Christian D. R., Heeg J. F. Fed. Proc 1970; 29: 356
- Schwandt P., Weisweiler P., Neureuther G. Artery 1979; 5: 117–124
- Smith T. C. Proc. R. Soc. Med. 1976; 69: 24–25
- Okerholm R. A., Keeley F. J., Peterson F. E., Glazko A. J. Fed. Proc 1976; 35: 327
- Abshagen U., Bablok W., Koch K., Lang P. D., Schmidt H. A. E., Senn M., Stork H. Eur. J. Clin. Pharmacol 1979; 16: 31–38
- Endele R. J. Chromatogr 1978; 154: 261–263
- Elsom L. F., Hawkins D. R., Chasseaud L. F. J. Chromatogr 1976; 123: 463–467
- Brodie R. R., Chasseaud L. F., Elsom F. F., Franklin E. R., Taylor T. Arzneim.-Forsch 1976; 26: 896–901
- Desager J. P., Harvengt C. Int. J. Clin. Pharmacol 1978; 16: 570–574
- Desager J. P. J. Chromatogr 1978; 145: 160–164
- Drouin P., Mejean L., Lambert D., Sauvanet J. P., Debry G., Toume C., Wulfert E. Curr. Ther. Res. 1979; 26: 357–362
- Olsson A. G., Oro L., Carlson L. A. Fifth International Symposium on Atherosclerosis, Houston, Texas, November, 6–91979, Abstract No. 160
- Davison C., Benziger D., Fritz A., Edelson J. Drug Metab. Dispos 1975; 3: 520–524
- Edelson J., Benziger D. P., Arnold A., Beyler A. L. Atherosclerosis 1979; 33: 351–357
- St. Janiak P. Drugs of the Future 1979; 4: 140–147
- Samuel P. New Engl. J. Med. 1979; 301: 595–597
- Gallo D. G., Sheffner A. L. Proc. Soc. Exp. Biol. Med. 1965; 120: 91–93
- Thomas R. C., Hsi R. S. P., Harpootlian H., Johnson T. D., Judy R. W. Atherosclerosis 1978; 29: 9–23
- Simons L. A. Clin. Exp. Pharmacol. Physiol 1976; 3: 99–101
- Jahnchen E., Meinertz T., Gilfrich H.-J., Kersting F., Groth U. Br. J. Clin. Pharmacol 1978; 5: 437–440
- Caldwell J. H., Bush C. A., Greenberger N. J. J. Clin. Invest 1971; 50: 2638–2644
- Brown D. D., Juhl R. P., Warner S. L. Circulation 1978; 58: 164–174
- Bazzano G., Bazzano G. S. J. Am. Med. Assoc 1972; 220: 828–830
- Boylan J. J., Egle J. L., Guzelian P. S. Science 1978; 199: 893–895
- Cohn W. J., Boylan J. J., Blanke R. V., Fariss M. W., Howell J. R., Guzelian P. S. New Engl. J. Med. 1978; 298: 243–248
- Bennett P. N., Adams D. J., Uttley A. H. C., Gaya H. Eur. J. Clin. Invest 1976; 6: 323
- Johansson C., Adamsson U., Stierner U., Lindsten T. Acta Med. Scand 1978; 204: 509–512
- Northcutt R. C., Stiel J. N., Hollifield J. W., Stant E. G., Jr. J. Am. Med. Assoc 1969; 208: 1857–1861
- Kauffman R. E., Azarnoff D. L. Clin. Pharmacol. Ther 1973; 14: 886–890
- Hunninghake D. B., King S. Pharmacologist 1978; 20: 220
- Hahn K.-J., Eiden W., Schettle M., Hahn M., Walter E., Weber E. Eur. J. Clin. Pharmacol 1972; 4: 142–145
- Harvengt C., Desager J. P. Eur. J. Clin. Pharmacol 1973; 6: 19–21
- Brown D. D., Juhl R. P., Warner S. L. Drug Metab. Rev. 1979; 9: 107–117
- Hahn K.-J., Hahn M.-L. Arch. Pharmacol 1976; 294: R8
- Dordoni B., Willson R. A., Thompson R. P. H., Williams R. Br. Med. J. 1973; 3: 86–87
- Barnard D. L., Heaton K. W. Gut 1973; 14: 316–318
- West R. J., Lloyd J. K. Gut 1975; 16: 93–98
- Coronato A., Glass G. B. J. Proc. Soc. Exp. Biol. Med. 1973; 142: 1341–1344
- Gallo D. G., Bailey K. R., Sheffner A. L. Proc. Soc. Exp. Biol. Med. 1965; 120: 60–65
- Ko H., Royer M. E. J. Pharm. Sci. 1974; 63: 1914–1920
- Nolan J. P., Ali M. V. Am. J. Dig. Pis. 1972; 17: 161–166
- Rosenberg H. A., Bates T. R. Proc. Soc. Exp. Biol. Med. 1974; 145: 93–98
- Tembo A. V., Bates T. R. J. Pharmacol. Exp. Ther 1974; 191: 53–59
- Pieniaszek H. J., Jr., Bates T. R. J. Pharmacol. Exp. Ther 1976; 198: 240–245
- Salen G., Ahrens E. H., Jr., Grundy S. M. J. Clin. Invest 1970; 49: 952–967
- Gould R. G., Jones R. J., Le Roy G. V., Wissler R. W., Taylor C. B. Metabolism 1969; 18: 652–662
- Lees R. S., Lees A. M. Lipoprotein Metabolism, H. Greten. Springer, Berlin 1976; 117–124
- Bhattacharyya A. K., Connor W. E. J. Clin. Invest 1974; 53: 1033–1043
- Shulman R. S., Bhattacharyya A. K., Connor W. E., Fredrickson D. S. New Engl. J. Med. 1976; 294: 482–483
- Subbiah M. T. R. Am. J. Clin. Nutr 1973; 26: 219–225
- Sugano M., Morioka H., Ikeda I. J. Nutr 1977; 107: 2011–2019
- Ikeda I., Sugano M. Atherosclerosis 1978; 30: 227–237
- Breen K. J., Bryant R. E., Levinson J. D., Schenker S. Ann. Intern. Med. 1972; 76: 211–218
- Kendall M. J., Chan K. Xenobiotica 1973; 3: 727–744
- Longstreth G. F., Newcomer A. D. Mayo Clin. Proc 1975; 50: 284–293
- Barrowman J. A., D'Mello A., Herxheimer A. Eur. J. Clin. Pharmacol 1973; 5: 199–202
- Lindenbaum J., Maulitz R. M., Butler V. P., Jr. Gastroenterology 1976; 71: 399–404
- Black C. D., Popovich N. G. Drug. Intell. Clin. Pharm 1975; 9: 586–590, and references cited
- Cayen M. N., Dvornik D. J. Lipid Res. 1979; 20: 162–174
- Cayen M. N., Ferdinandi E. S., Greselin E., Dvornik D. Atherosclerosis 1979; 33: 71–87
- Cayen M. N., Dvornik D. Atherosclerosis 1978; 29: 317–327